Indiana legislators have been filing bills for the 2026 legislative session and some of the bills have a lighthearted goal.

Under Indiana’s current e-filing system, there are three avenues of e-filing: regular routes, e-filing for protective orders ...

Northstrive Biosciences has received preliminary feedback from the FDA on its nonclinical studies and clinical plans for its product, EL-22, intended for use alongside GLP-1 receptor agonists in ...

Shattuck Labs, Inc. has announced progress in its SL-325 program, with an Investigational New Drug (IND) filing expected in the third quarter of 2025. The company reported a cash balance of ...

HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeuti ...

BERKELEY, Calif., Sept. 24, 2025 /PRNewswire/ -- ResVita Bio, a biotechnology company pioneering continuous protein therapy for skin diseases, today announced the successful completion of a ...

FibroBiologics submits IND application with US FDA to initiate clinical trials of CYPS317 in psoriasis patients: Houston Saturday, January 3, 2026, 11:00 Hrs [IST] FibroBiologics ...

NRx Pharmaceuticals (NRXP) amended its Investigational New Drug filing for NRX-101 to include the use of NRX-101 in association with Transcranial Magnetic Stimulation for the treatment of depression, ...

Indiana leaders are working to get a monument displaying the Ten Commandments returned to the Statehouse grounds.

Indiana is beginning a new college financial aid season seeking a repeat of last year’s success in getting high school seniors to submit a form that can provide access to more than $1.4 billion. The ...

Election-2026-Redistricting FILE - Annette Groos holds a sign before the start of a rally featuring former Transportation Secretary Pete Buttigieg at the Statehouse in Indianapolis, Thursday, Sept. 18 ...

SHANGHAI and SANTA BARBARA, Calif., Sept. 15, 2025 /PRNewswire/ --Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced today the successful submission of ...